Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1990-09-28
1993-09-14
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Lymphokine
424 92, A61K 3910
Patent
active
052446573
ABSTRACT:
A new method is described for the preparation of a safe, immunogenic and efficacious vaccine for protection against the disease pertussis. In development of this vaccine, specific functional sites of pertussis toxin have been identified, and using this information, defined mutant holotoxins have been produced by site directed mutagenesis of the toxin gene. A number of these holotoxin analogs are detoxified, retain an immunodominant S1 epitope, are immunogenic and are protective in the standard pertussis vaccine potency test in mice.
REFERENCES:
Pizza et al. "Pertussis Toxin CRMs and New Vaccines Against Whooping Cough" in Bacterial Protein Toxins, Zbl. Bakt. Suppl. 19, 1990.
Pizza et al "Mutants of Pertussis Toxin Suitable for Vaccine Development" Science, vol. 246, pp. 497-500 Oct. 27, 1989.
Burnette et al. "Pertussis S1 Mutant with Reduced Enzyme Activity and a Conserved Epitope" Science vol. 242, pp. 72-74, Oct. 7. 1988.
Moss et al., J. Biol. Chem. 258, 11879 [1983].
Locht and Keith, Science 232, 1258 [1986].
Carrol & Collier, Proc. Nat. Acad. Sci., U.S.A., 81, 3307 [1984].
Moss et al., J. Biol. Chem. 258, 11879 [1983].
Locht and Keith, Science 232, 1258 [1986].
Carrol & Collier, Proc. Nat. Acad. Sci., U.S.A., 81, 3307 [1984].
Carroll & Collier, J. Biol. Chem., 262, 8707 [1987].
Nogimori et al, Biochem., 25, 1355 [1986].
Armstrong & Peppler, Infec. Immun., 55, 1294 [1987].
Tweten et al., J. Biol. Chem., 260, 10392 [1984].
Douglas & Collier, J. Bacteriol., 169, 4967, [1987].
Locht et al., Infect. Immun., 55, 2546, [1987].
Black et al., Ann. Sclavo, 175, [1986].
Black & Falkow, Infect. Immun., 55, 2465, [1987].
Burns et al., Infet. Immun., 55, 24, [1987].
Watkins et al., J. Biol. Chem., 260, 13478, [1985].
Ditta et al., Plasmid, 13, 149, [1985].
Kahn et al., Methods in Enzymology, 68, 278, [1979]*.
Nicosia et al, Proc. Nat. Acad. Sci., U.S.A., 83, 4631, [1986].
Arico & Rappuoli, J. Bacteriol., 169, 2849, [1987].
Gene, vol. 50, 1986, pp. 133-140; Elsevier; S. Stibitz et al.: "The Construction of a cloning vector designed for gene replacement in Bordetella pertussis".
Biochemistry, vol. 21, 1982, pp. 5516-5522, American Chemical Society; M. Tamura et al.: "Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B mode"*.
Chemical Abstracts, vol. 105, No. 19, Nov. 10, 1986, ref. No. 166239w: Columbus, Ohio, US.
J. Reiser et al.: "Expression in Escherichia coli of a Bordetella pertussis toxin-coding region" & Vaccines 86, New Approaches Immun. (Proc. Conf.) 1985 (Pub. 1986), 235-8*.
Infection and Immunity, vol. 56, No. 8, Aug. 1988, pp. 1934-1941.
J. T. Barbieri et al.: "ADP-ribosyl transferase mutations in the catalytic S-1 subunit of pertussis toxin" Science, vol. 242, No. 4875, 1988, pp. 72-74.
Infection and Immunity, vol. 55, No. 4, Apr. 1987, pp. 963-967.
A. Nicosia et al.: "Expression and immunological properties of the five subunits of pertussis toxin".
Burnette et al; "Pertussis Toxin S1 Mutant with Reduced Enzyme Activity and a Conserved Protective Epitope" Science--vol. 242, No. 487, 1988, pp. 72-74.
EP-A-145 486 (Glaxo Group Ltd.) p. 4, lines 12-27; p. 6, line 22, p. 9, line 12; example 2.
EP-A-0087 735 (Takeda chemical Industries) p. 7, line 15-24.
Chemical Abstracts, vol. 106, No. 11, 16th Mar. 1987, p. 163, abstract No. 79657h, Columbus, Ohio, US.
J. M. Keith et al: "Pertussis toxin gene cloning and expression of protective antigen", & US-A-843 727 (United States Dept. of Health and Human Services) 20-06-1986 *Abstract*.
Chemical Abstracts, vol. 106, No. 5, 2nd Feb. 1987, p. 120, abstract No. 28346y, Columbus, Ohio, US.
R. M. Brownlie et al.: "Complementation of mutations in Escherichia coli and Bordetella pertussis by B. pertussis DNA cloned in a broad-host-range cosmid vector", & J. Gen. Michrobiol. 1986, 132(11), 3221-9 *Abstract*.
Boux Heather A.
Cockle Stephen A.
Klein Michel H.
Loosmore Sheena M.
Zealey Gavin R.
Connaught Laboratories Limited
Hill Jr. Robert J.
Ossanna Nina
LandOfFree
Genetic detoxification of pertussis toxin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic detoxification of pertussis toxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic detoxification of pertussis toxin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2024801